Similarly, p53 and p21 were significantly (P = 1.1 × 10−5, P = 2.2 × 10−9) higher in the OC users of the BC group by 44.1% and 71.3% with respect to the OC users of the control group; with the telomerase being non-significantly different. The gene discussed is TP53; the disease is breast cancer.